NDC 66215-628 Uptravi Titration Pack
Selexipag Kit - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 66215 - Actelion Pharmaceuticals Us, Inc.
- 66215-628 - Uptravi Titration Pack
Product Characteristics
RED (C48326 - RED)
PURPLE (C48327 - LIGHT VIOLET)
GREEN (C48329 - GREEN)
ORANGE (C48331 - ORANGE)
PURPLE (C48327 - DARK VIOLET)
YELLOW (C48330 - DARK YELLOW)
BROWN (C48332 - BROWN)
4
6
8
10
12
14
16
Product Packages
NDC Code 66215-628-20
Package Description: 1 KIT in 1 CARTON * 1 BOTTLE in 1 CARTON / 140 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON / 60 TABLET, COATED in 1 BOTTLE
Product Details
What is NDC 66215-628?
What are the uses for Uptravi Titration Pack?
Which are Uptravi Titration Pack UNII Codes?
The UNII codes for the active ingredients in this product are:
- SELEXIPAG (UNII: 5EXC0E384L)
- SELEXIPAG (UNII: 5EXC0E384L) (Active Moiety)
Which are Uptravi Titration Pack Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- STARCH, CORN (UNII: O8232NY3SJ)
- LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 2165RE0K14)
- HYDROXYPROPYL CELLULOSE (1200000 MW) (UNII: RFW2ET671P)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
What is the NDC to RxNorm Crosswalk for Uptravi Titration Pack?
- RxCUI: 1729007 - selexipag 1000 MCG Oral Tablet
- RxCUI: 1729007 - selexipag 1 MG Oral Tablet
- RxCUI: 1729013 - Uptravi 1000 MCG Oral Tablet
- RxCUI: 1729013 - selexipag 1 MG Oral Tablet [Uptravi]
- RxCUI: 1729013 - Uptravi 1 MG Oral Tablet
* Please review the disclaimer below.
Patient Education
Selexipag
Selexipag is used in adults to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) to slow down the worsening of symptoms and reduce the chance of being hospitalized for PAH. Selexipag is in a class of medications called selective nonprostanoid IP prostacyclin receptor agonists. It works by relaxing the blood vessels in the lungs to allow blood to flow easily.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".